Area of research
Dermatology · Pathology and Forensic Medicine
Research interest
Research interests include Cutaneous lymphoproliferative disorders research, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, and Viral-associated cancers and disorders.
Dual-Targeted Therapy with Ruxolitinib Plus Duvelisib for T-Cell Lymphoma
A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas
Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell Lymphoma
Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile
Durable Responses Observed with JAK Inhibition in T-Cell Lymphomas
Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma
<scp>ALK</scp>‐positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)
Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors
Dermoscopic Findings in Cutaneous Metastases
Primary cutaneous B-cell lymphomas
Primary cutaneous B-cell lymphomas
Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma